Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) — Stella

Home/Pancreatic Adenocarcinoma/Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

View on ClinicalTrials.gov

Recruiting

Back to Pancreatic Adenocarcinoma trials

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

Ireland

St Luke's Radiation Oncology Network (SLRON), Dublin

St Vincent's University Hospital, Dublin

Key details

Phase

Early testing / Safety & dosing

Sponsor

Cancer Trials Ireland

Enrollment target

~49 participants

Started

January 2024

Primary completion

July 2027

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.